Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
This cell line lacks the expression of all PARKIN isoforms and is valuable for elucidating the role of PARK2 mutations in PD.
|
31698191 |
2019 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
[Function of Parkin].
|
12138708 |
2002 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The parkin gene on chromosome 6q and loci on chromosome 1p35-36 and 1p36 are responsible for some cases of autosomal recessive early-onset parkinsonism, but they do not appear to influence susceptibility or variability of age at onset for idiopathic PD.
|
11920285 |
2002 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Parkin, a RING-between-RING-type E3 ubiquitin ligase associated with Parkinson's disease, has a wide neuroprotective activity, preventing cell death in various stress paradigms.
|
23453807 |
2013 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Exon rearrangements in the PARK2 gene play a significant role in the pathogenesis of sporadic PD in Russian patients.
|
21915905 |
2012 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease.
|
12975291 |
2003 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Parkin, an E3 ubiquitin ligase, is the most frequently mutated gene in hereditary Parkinson's disease.
|
29138676 |
2017 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
A subset of familial PD is linked to mutations in PARK2 and PINK1, which lead to dysfunctional mitochondria-related proteins Parkin and PINK1, suggesting that pathways implicated in these monogenic forms could play a more general role in PD.
|
27641647 |
2016 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
|
23531835 |
2013 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Parkin gene mutation testing was performed in young onset PD (diagnosed <50 years old) to identify three groups: Parkin homozygous or compound heterozygote mutation carriers, Parkin single heterozygote mutation carriers, and non-carriers of Parkin mutations.
|
26626018 |
2016 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The clinical relevance of our findings is substantiated by the discovery of homozygous PARKIN (<i>PARK2</i>) p.S65N mutations in two unrelated patients with PD.
|
30404819 |
2018 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PARK2/Parkin, which encodes a ubiquitin E3 ligase, cause autosomal recessive Parkinson disease (PD).
|
20823226 |
2010 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
|
18486522 |
2009 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
From 102 patients, 40 with early-onset PD (<45 years at symptomatic onset) were selected for clinical assessment and parkin gene molecular analysis for duplications/deletions and point mutations.
|
15197707 |
2004 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Parkin is a ligase involved in ubiquitin-proteasome pathway and mutations in the parkin gene are the most common cause of recessive familial Parkinson's disease.
|
23146297 |
2012 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In the present report we have screened a cohort of Parkinson disease patients (n = 57) and healthy controls (n = 51) from Nigeria for mutations in the genes PRKN, LRRK2 and ATXN3.
|
18927607 |
2008 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Genes which have been implicated in autosomal-recessive PD include PARK2 which codes for parkin, an E3 ubiquitin ligase that participates in a variety of cellular activities.
|
25399302 |
2015 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The turnover of damaged mitochondria by mitophagy is initiated by the Parkinson disease-linked genes PRKN and PINK1, and we recently investigated the role that interorganellar contact sites between the endoplasmic reticulum (ER) and the outer mitochondrial membrane (OMM) play in this pathway.
|
30081712 |
2018 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.
|
25939424 |
2015 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We observed that amino acids in Parkin targeted by nonsynonymous T1R-risk mutations were also enriched for mutations implicated in PD (<i>P</i> = 1.5 × 10<sup>-4</sup>).
|
31308240 |
2019 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We assessed point mutations and exon deletions and duplications in the Parkin gene in 247 probands with PD (age at onset < or =50 years) and 104 control probands enrolled in the Genetic Epidemiology of Parkinson's Disease (GEPD) study.
|
18413468 |
2008 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PARKIN, PTEN-induced kinase 1 (PINK1) and DJ-1 are found in autosomal recessive forms and some sporadic cases of Parkinson's disease.
|
17499497 |
2007 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
An early-onset form of Parkinson's disease is associated with mutations in the PINK1 kinase and PRKN ubiquitin ligase genes<sup>3</sup>.
|
31316206 |
2019 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EOPD probands and their first-degree relatives who did not have Parkinson's disease (PD) were genotyped for mutations in the parkin gene and administered a comprehensive neuropsychological battery.
|
21092386 |
2011 |
Parkinson Disease
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
The point mutations on exon 2 of parkin gene were detected using polymerase chain reaction(PCR), agarose electrophoresis, single strand conformation polymorphism(SSCP), DNA sequencing and analysis of restrict enzyme in DNA of 60 Parkinson's disease patients with an onset age under 50 and 120 normal controls.
|
12362318 |
2002 |